HIGHLIGHTS
- who: . et al. from the Istanbul University-Cerrahpasa, Turkey have published the paper: Anticancer potential of mebendazole against chronic myeloid leukemia: in silico and in vitro studies revealed new insights about the mechanism of action, in the Journal: (JOURNAL)
- what: The DR studies aim to discover new pharmacologic mechanisms and new molecular targets for known drugs to reach new applications (Gurova, 2009).
- how: Together these results indicated that ABL1 could be a potential target for MBZ based on the ChEMBL database.
SUMMARY
MBZ has proved its antitumoral activity extensively . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.